TNL Mediagene (TNMG)

TNL Mediagene is a Tokyo-based media company with operations in Taiwan and Japan. Its portfolio includes a range of digital news, lifestyle, business, technology, and culture properties such as The News Lens, Business Insider Japan, Business Yee, DIGIDAY JAPAN, GLOSSY JAPAN, Gizmodo Japan, Cool3c, Tech Insider, INSIDE, iCook, Lifehacker Japan, ROOMIE, every little d, Sports Vision, Agent Movie, Fuze, and Sirabee. The company also operates event, conference, and specialized content businesses, alongside activities in artificial intelligence, advertising technology, digital studio services, and e-commerce. TNL Mediagene is listed on NASDAQ under the ticker TNMG as common stock.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-TNMG
$14 4,017.6% Upside
Bargain
Weak
0.0%
0.0x
0.0x
0.0x
830.064 K
19.159 M
92.4%
-36.1
13.4%
Valuation • Fair Value

TNL Mediagene (NASDAQ-TNMG) Fair Value by Valuation Model

Compare the primary fair value estimate for TNL Mediagene (NASDAQ-TNMG) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Fair Value Confidence

Very low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

NM

Comparable-company valuation reference.

Analyst Price Target

$14 4,017.6% Upside

Current consensus analyst target, where available.

How to read these valuation models

Use this section to compare the primary fair value estimate for TNL Mediagene (NASDAQ-TNMG) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for TNL Mediagene (NASDAQ-TNMG)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

Not available

Data is currently unavailable.

Revenue Forecast

49.087 M

Forward revenue estimate.

EBITDA

0 K

Current operating profitability reference.

EBITDA Forecast

-3.288 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review TNL Mediagene (NASDAQ-TNMG) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for TNL Mediagene (NASDAQ-TNMG)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

1

Weak quality score that deserves closer review.

Beneish M-Score

-6.89

No elevated caution signal from this screen.

Altman Z-Score

-36.1

Lower score that deserves closer risk review.

FCF / Net Income

13.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for TNL Mediagene (NASDAQ-TNMG). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for TNL Mediagene (NASDAQ-TNMG)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

Not available

Days to Earnings

Not available

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for TNL Mediagene (NASDAQ-TNMG), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

TNL Mediagene (NASDAQ-TNMG) Stock Forecast & Technical Outlook

Review TNL Mediagene (NASDAQ-TNMG) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for TNL Mediagene (NASDAQ-TNMG) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Buy

The 1-hour technical read for TNL Mediagene (NASDAQ-TNMG) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for TNL Mediagene (NASDAQ-TNMG) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for TNL Mediagene (NASDAQ-TNMG) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for TNL Mediagene (NASDAQ-TNMG) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for TNL Mediagene (NASDAQ-TNMG)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, TNL Mediagene (NASDAQ-TNMG) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ Fast Investor Answers

TNL Mediagene (NASDAQ-TNMG) Stock FAQ

Quick answers about TNL Mediagene (NASDAQ-TNMG) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
Not available
Data is currently unavailable
Valuation Rating
Not available
Classification is not available
Analyst Target
$14 4,017.6% Upside
Data is currently unavailable
Financial Health
Weak
Current financial-health read

A fair value estimate for TNL Mediagene (NASDAQ-TNMG) is not currently available in the latest data file.

A clear undervalued or overvalued classification is not currently available in the latest data file.

The available analyst price target for TNL Mediagene (NASDAQ-TNMG) is $14 4,017.6% Upside.

The current financial health read for TNL Mediagene (NASDAQ-TNMG) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for TNL Mediagene (NASDAQ-TNMG) is 0.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for TNL Mediagene is 830.064 K.

The current enterprise value listed for TNL Mediagene is 19.159 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for TNL Mediagene is NASDAQ-TNMG, and the stock is listed on NASDAQ.

TNL Mediagene (NASDAQ-TNMG) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for TNL Mediagene is 92.4%, which helps investors evaluate the company’s financing structure and leverage profile.